Compare Cassava Sciences Inc (FLNA) vs Oxford Lane Capital Corp (OXLC) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Oxford Lane Capital Corp. (OXLC) trades at $9.005, down 1.37% on the day, amid a bearish technical signal and severe fundamental deterioration. The stock's price-to-book ratio of 0.85 suggests undervaluation relative to assets, but this is overshadowed by catastrophic earnings misses, a negative return on equity of -39.16%, and a projected revenue collapse into negative territory for 2026, as indicated in recent financial trends.

The outlook is highly risky. While a 50% analyst buy consensus and a high dividend yield present a speculative income opportunity, the core risks are substantial, including unsustainable distributions funded by dilution, rapid net asset value erosion, and significant operational cash outflows, as highlighted in critical Seeking Alpha reports from May 2026.